CancerNetwork·4 min read·hard
26 A Nomogram for Predicting High Axillary Disease Burden in Patients With Localized HR+, HER2-Negative Breast Cancer Following Neoadjuvant Chemotherapy
N
Neha Kalakuntla, Yulun Liu, Holly Grace, Marilyn Leitch, Asal Rahimi, Mona Arbab, Narine Wandrey, Deborah Farr, MD, Heather McArthur, MD, MPH, Sunati Sahoo, Stephen Seiler, Prasanna Alluri
✦AI Summary
Researchers at UT Southwestern and Parkland hospitals developed a nomogram to predict high axillary disease burden in breast cancer patients. The study identifies lymphovascular invasion and sentinel lymph node status as key predictors to help avoid unnecessary surgeries.
Background
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in